PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Molecular Toxicology, Research Group Intestinal Microbiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Arthur-Scheunert-Allee 114-116, Nuthetal, Brandenburg, 14558, Germany.\', \'Research Unit \'Biotechnology in Nutraceuticals and Bioactive Compounds-BIONUC\', Departamento de Biología Funcional, Área de Microbiología, Universidad de Oviedo, Oviedo, Spain.\', \'Instituto Universitario de Oncología del Principado de Asturias, Oviedo, Spain.\', \'Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.\', \'Department of Systems Biology, Centro Nacional de Biotecnología, CSIC, Madrid, Spain.\', \'Department of Biotechnology & Enzyme Catalysis, Institute of Biochemistry, University Greifswald, Felix-Hausdorff-Str. 4, Greifswald, D-17487, Germany.\', \'Interdisciplinary Platform for Sustainable Plastics towards a Circular Economy-Spanish National Research Council (SusPlast-CSIC), Madrid, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/1751-7915.13675
?:doi
?:hasPublicationType
?:journal
  • Microbial biotechnology
is ?:pmid of
?:pmid
?:pmid
  • 33047877
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.275
?:rankingScore_hIndex
  • 48
is ?:relation_isRelatedTo_publication of
?:title
  • Repositioning microbial biotechnology against COVID-19: the case of microbial production of flavonoids.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33047877>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33047877>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all